Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Nathanson

Showing results (281-290 of 528) with videos related to

Pageof 53
Sort By:
Breast Cancer Research and Treatment|June 11, 2008
No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriersAmanda B Spurdle, Andrew J Deans, David Duffy, et al.
Clinical Genetics|September 12, 2022
Fanconi anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthoodKara N Maxwell, Vishal Patel, Kevin T Nead, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2015
Copy Number Changes Are Associated with Response to Treatment with Carboplatin, Paclitaxel, and Sorafenib in MelanomaMelissa A Wilson, Fengmin Zhao, Sanika Khare, et al.
Endocrine-Related Cancer|October 14, 2015
Rare inactivating PDE11A variants associated with testicular germ cell tumorsAnand Pathak, Douglas R Stewart, Fabio R Faucz, et al.
Genes, Chromosomes & Cancer|May 13, 2011
Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcomeJia Huang, Lin Zhang, Joel Greshock, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 15, 2012
Copy number variation in pediatric multiple sclerosisJ P McElroy, L B Krupp, B A Johnson, et al.
Medrxiv : the Preprint Server for Health Sciences|August 23, 2023
A genotype-first approach identifies high incidence of <i>NF1</i> pathogenic variants with distinct disease associationsAnton Safonov, Tomoki T Nomakuchi, Elizabeth Chao, et al.
JCO Precision Oncology|February 26, 2020
Returning Individual Genetic Research Results to Research Participants: Uptake and Outcomes Among Patients With Breast CancerAngela R Bradbury, Linda Patrick-Miller, Brian L Egleston, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Performance of polygenic risk scores for cancer prediction in a racially diverse academic biobankLouise Wang, Heena Desai, Shefali S Verma, et al.
Pigment Cell & Melanoma Research|February 7, 2016
Enhancing the evaluation of PI3K inhibitors through 3D melanoma modelsBatool Shannan, Quan Chen, Andrea Watters, et al.
Pageof 53

Showing results (281-290 of 528) with videos related to

Sort By:
Pageof 53
Breast Cancer Research and Treatment|June 11, 2008
No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriersAmanda B Spurdle, Andrew J Deans, David Duffy, et al.
Clinical Genetics|September 12, 2022
Fanconi anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthoodKara N Maxwell, Vishal Patel, Kevin T Nead, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2015
Copy Number Changes Are Associated with Response to Treatment with Carboplatin, Paclitaxel, and Sorafenib in MelanomaMelissa A Wilson, Fengmin Zhao, Sanika Khare, et al.
Endocrine-Related Cancer|October 14, 2015
Rare inactivating PDE11A variants associated with testicular germ cell tumorsAnand Pathak, Douglas R Stewart, Fabio R Faucz, et al.
Genes, Chromosomes & Cancer|May 13, 2011
Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcomeJia Huang, Lin Zhang, Joel Greshock, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 15, 2012
Copy number variation in pediatric multiple sclerosisJ P McElroy, L B Krupp, B A Johnson, et al.
Medrxiv : the Preprint Server for Health Sciences|August 23, 2023
A genotype-first approach identifies high incidence of <i>NF1</i> pathogenic variants with distinct disease associationsAnton Safonov, Tomoki T Nomakuchi, Elizabeth Chao, et al.
JCO Precision Oncology|February 26, 2020
Returning Individual Genetic Research Results to Research Participants: Uptake and Outcomes Among Patients With Breast CancerAngela R Bradbury, Linda Patrick-Miller, Brian L Egleston, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Performance of polygenic risk scores for cancer prediction in a racially diverse academic biobankLouise Wang, Heena Desai, Shefali S Verma, et al.
Pigment Cell & Melanoma Research|February 7, 2016
Enhancing the evaluation of PI3K inhibitors through 3D melanoma modelsBatool Shannan, Quan Chen, Andrea Watters, et al.
Pageof 53